A recent study investigated the effects of GLP-1R agonists in a multi-hit mouse model in which the combination of a high-fat diet and angiotensin II-induced a cardiometabolic HFpEF phenotype that resembles the human HFpEF phenotype to a large extent characterized by obesity, impaired glucose handling, and metabolic dysregulation accompanied by inflammation
"Ozempic butt" refers to the loss of muscle and fat in the glutes that can happen with rapid weight loss a common concern for people taking GLP-1 medications
In April 2026, the FDA granted approval to two oral GLP-1 treatments, Eli Lillys Foundayo, made with orforglipron, and Novo Nordisks semaglutide pill, also called Wegovy
Semaglutide is available in different versions: Wegovy : A weekly injectable approved for weight loss in adults and children aged 12 and older with obesity
Final Thoughts on Semaglutide Weight Loss Semaglutide can be an effective mechanism for weight loss, but it should not be seen as a miracle cure